Free Trial

Iradimed Q4 2024 Earnings Report

Iradimed logo
$52.45 +1.01 (+1.96%)
As of 03/14/2025 04:00 PM Eastern

Iradimed EPS Results

Actual EPS
$0.40
Consensus EPS
$0.45
Beat/Miss
Missed by -$0.05
One Year Ago EPS
N/A

Iradimed Revenue Results

Actual Revenue
$19.39 million
Expected Revenue
$19.09 million
Beat/Miss
Beat by +$300.00 thousand
YoY Revenue Growth
N/A

Iradimed Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Remove Ads

Iradimed Earnings Headlines

Iradimed (NASDAQ:IRMD) Rating Lowered to Buy at StockNews.com
Alert: DOGE goes live
Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.
See More Iradimed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Iradimed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Iradimed and other key companies, straight to your email.

About Iradimed

Iradimed (NASDAQ:IRMD) Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

View Iradimed Profile

More Earnings Resources from MarketBeat